▶주메뉴 바로가기
▶본문 바로가기
South Korean new drug developer GemVax & KAEL announced on March 13 that it has recruited 90 patients to conduct phase 2 clinical trials of its treatment for Alzheimer’s disease. “Since the trials...
LG Chem, South Korea’s top chemical firm, said on March 11 it has received a $33.4 million grant from the Bill & Melinda Gates Foundation to develop a new combination vaccine. The grant will be u...
Celltrion Healthcare announced on March 11 that it won bids to supply Remsima and Truxima to two Southeast Asian countries at the end of last year. For this year, the company will be exclusively sup...
Stonebridge Ventures, spun-off from Korean private equity firm Stonebridge Capital, will invest more in the bio industry this year, according to industry sources on March 8. “Recently, we saw growin...
Korean biopharmaceutical firm Samsung Bioepis will spend 180.4 billion won (US$159.70) to build a new research and development center, its parent company said Thursday. The investment cost accoun...
Daewoong Pharmaceutical announced on March 6 that it posted sales of 1.31 trillion won (US$ 1.16 billion) last year. It has became one of the few Korean pharma firms to reach the milestone. Three ot...
SillaJen aims to secure around 220 billion won (US$194.89 million) fresh funds through issuing convertible bonds, according to industry sources on March 7. It has picked Kium Securities to organize ...
Stock exchange operator Korea Exchange has blocked condom maker Bio Genetics from getting representation on Kyung Nam Pharm’s board, according to industry sources on Mar. 6. Bio Genetics, which boug...
Korean biopharmaceutical firm Samsung Bioepis said on March 5 it has won approval from European authorities for the sale of mass dosages of its biosimilar drug Ontruzant. The European Medicines A...
Hypertension drugs gained unwanted attention in South Korea last year: More than 170 generic drugs sold by 76 local drugmakers were recalled by the Drug Ministry for their inclusion of valsartan, a c...
Ildong Pharmaceutical’s multivitamin series Aronamin was the best-selling over the counter drug for the third consecutive year in 2018. OTC drugs can be purchased directly at medical stores without ...
Korean cosmetics manufacturer Kolmar Korea has decided to issue corporate bonds worth 100 billion won (US$89.35 million), according to industry sources on Feb. 28. Mirae Asset Daewoo is organizing i...
Celltrion Pharm, the generic arm of Celltrion, announced on Feb. 27 that it has decided to inject 58.2 billion won for establishing its Remsima SC production facility at its plant in Cheongju, North ...
SK Biopharmaceuticals, the new drug development unit of Korea’s telecom-to-energy conglomerate SK Group, is considering exporting its drug candidate Cenobamate to Japan, according to industry sources...
Hong Kong-based global private equity firm Anchor Equity Partners plans to sell its 47 percent stake in Korean top drug retailer Geoyoung, according to industry sources on Feb. 25. The PEF has repor...
[Market Close-up] S. Korean stock market recovers faster than other markets
One Equity Partners to unload Celltrion Healthcare stake at discount
Local telecom firms bid for fifth-largest cable TV operator Hyundai HCN
IBK fined $86m in US over mishandling anti-money laundering program
Acleda Bank lists on KRX-invested Cambodian stock exchange
Samsung Biologics bags CMO deals worth W468b
Tmon vows to turn profit by 10th anniversary
Macrogen’s COVID-19 test kit approved for export
May 28, 2020
![[Market Close-up] S. Korean stock market recovers faster than other markets](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=151&simg=/content/image/2020/05/27/20200527000702_0.jpg&md=20200527162557)
